afatinib for Lung Cancer: 10 Real Stories
10 stories match lung cancer and afatinib. 9 of them mention targeted therapy.
Stage IV Lung Cancer: Carla’s Patient Story
Carla lived with lung cancer that repeatedly developed resistance to treatment. For long periods, her symptoms were limited mainly to coughing and manageable fatigue. In January 2015, while taking third-line afatinib, she married Bud and moved to Manila to…
Read this storyEGFR Lung Cancer Patient Story
This Noxte post was written from Asturias, where the patient had gone after an oncology visit in Majadahonda. The visit on 15 July focused on toxicity monitoring for AZD9291, the study drug he was receiving through a clinical trial. The checks were…
Read this storyLung Cancer Patient Story
This Noxte entry described a rapid change in treatment after a difficult scan. Oncology moved the patient’s planned June CT earlier to 25 May and also scheduled him to see his oncologist the same day. The reason became clear: the laboratory accepted an…
Read this storyLung Adenocarcinoma Patient Story
This Noxte post focused on pathology details that complicated the patient’s understanding of his lung cancer. A bronchoscopy performed on 5 February had produced a biopsy report from Hospital Puerta de Hierro. The tumor had first been understood as…
Read this storyEGFR Lung Cancer Patient Story
This Noxte entry followed a disappointing oncology update on 19 April. The patient learned that the blood sample sent to the laboratory was negative for T790M resistance, so he could not enter the AZD9291/osimertinib clinical trial. He found that frustrating…
Read this storyLung Cancer Patient Story
This Noxte entry reported a clear setback. On 12 April, the patient received CT results showing that the lung tumor was still growing. The right upper-lobe mass had increased from 4.9 by 5 cm to 5.7 by 6.5 cm. It was causing more narrowing of the apical…
Read this storyLung Cancer Patient Story
This Noxte entry was about uncertainty, one of the hardest parts of living with lung cancer. The patient had just had an oncology visit, but the blood result from the latest liquid biopsy was not available. He understood that the test was still part of a…
Read this storyLung Cancer Patient Story
This Noxte post explained how liquid biopsy was beginning to affect the patient’s lung cancer care. He had been participating in blood-based monitoring to track treatment effects and possible resistance. At an oncology visit, his doctors had the latest blood…
Read this storyLung Cancer Patient Story
By January 2016, this Spanish lung cancer blogger was marking 2 years of survival while facing a new treatment setback. Recent bronchoscopy and blood testing confirmed that the cancer had developed resistance, including the T790M mutation. That finding…
Read this storyEGFR Lung Cancer Patient Story
This lung cancer diary entry centers on the anxiety before a PET scan scheduled for December 9, 2014, at Hospital Puerta de Hierro in Majadahonda. The patient had gone 6 months without active treatment while waiting to see how the lung tumor evolved. During…
Read this story